SFM
APTO

Sphera Funds Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Sphera Funds Management’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-491
Closed -$1.42M – 145
2015
Q2 		$1.42M Buy
+491
New +$1.28M 0.14% 115

Other funds holding APTO

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Sphera Funds Management's APTO Position: Q3 2015 in Review

Sphera Funds Management sold out of Aptose Biosciences, Inc. (APTO) in Q3 2015, closing a stake of 491 shares — an estimated $1.42M sold.

Sphera Funds Management first reported a position in APTO in Q2 2015 and held it in 1 quarter. The position peaked at $1.42M in Q2 2015. 12 funds tracked by Wall St. Rank hold APTO as of Q3 2015.

  • Sphera Funds Management reported no remaining Aptose Biosciences, Inc. position as of Q3 2015 after selling out during the quarter.
  • Sphera Funds Management sold 491 Aptose Biosciences, Inc. shares in Q3 2015, an estimated $1.42M.
  • Sphera Funds Management first reported a position in Aptose Biosciences, Inc. in Q2 2015 and held it in 1 quarter.
  • Sphera Funds Management's Aptose Biosciences, Inc. position peaked at $1.42M in Q2 2015.
  • 12 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2015.

Based on Sphera Funds Management's 13F filing for Q3 2015, filed 16 Nov 2015.